CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World’s First Bispecific Antibody for Passive Immunization Against Rabies

SHENZHEN, CHINA – China Medical System Holdings Limited (867.HK/8A8.SG) (“CMS”, or the “Group”) is pleased to announce that, the New Drug Application for Silevimig Injection…

Read More CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World’s First Bispecific Antibody for Passive Immunization Against Rabies

The Pool Factory Strengthens Its Position as a Leading U.S. Provider of Above Ground Pools and Outdoor Living Products

Nationwide Expansion of Product Selection, Customer Support, and Online Shopping Experience Reinforces The Pool Factory’s Standing as America’s Above Ground Pool Experts EDISON, N.J., Jun 23,…

Read More The Pool Factory Strengthens Its Position as a Leading U.S. Provider of Above Ground Pools and Outdoor Living Products